adi-peg20
Showing 1 - 4 of 4
Hepatocellular Carcinoma Trial in Taoyuan (ADI-PEG20)
Recruiting
- Hepatocellular Carcinoma
- ADI-PEG20
-
Taoyuan, TaiwanChang Gung Memorial Hospital, Linkou branch
Sep 6, 2023
Nonalcoholic Steatohepatitis (NASH) Trial in Taiwan (ADI-PEG20, Placebo)
Not yet recruiting
- Nonalcoholic Steatohepatitis (NASH)
- ADI-PEG20
- Placebo
-
Kaohsiung, Taiwan
- +4 more
Apr 24, 2023
Glioblastoma Multiforme (GBM) Trial in Taoyuan (ADI-PEG20, Temozolomide)
Recruiting
- Glioblastoma Multiforme (GBM)
- ADI-PEG20
- Temozolomide
-
Taoyuan, TaiwanChang Gung Memorial Hospital, Linkou Branch
Sep 29, 2022
Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma Trial in Taiwan (ADI-PEG20, Placebo)
Recruiting
- Hepatocellular Carcinoma
- Advanced Hepatocellular Carcinoma
- ADI-PEG20
- Placebo
-
Changhua, Taiwan
- +8 more
Oct 19, 2022